Australasian Gastrointestinal Pathology Society (AGPS) consensus guidelines for universal defective mismatch repair testing in colorectal carcinoma.


Journal

Pathology
ISSN: 1465-3931
Titre abrégé: Pathology
Pays: England
ID NLM: 0175411

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 05 08 2018
revised: 18 11 2018
accepted: 25 11 2018
pubmed: 11 3 2019
medline: 30 5 2019
entrez: 11 3 2019
Statut: ppublish

Résumé

Lynch syndrome is the most common hereditary form of colorectal carcinoma caused by a constitutional pathogenic mutation in a DNA mismatch repair gene. Identifying Lynch syndrome is essential to initiate intensive surveillance program for the patient and affected relatives. On behalf of the Australasian Gastrointestinal Pathology Society (AGPS), we present in this manuscript consensus guidelines for Lynch syndrome screening in patients with colorectal carcinoma. The goal of this consensus document is to provide recommendations to pathologists for diagnosis of Lynch syndrome with discussion of the benefits and limitations of each test. Universal screening for defective mismatch repair is recommended, in agreement with the recent endorsement of universal testing by the National Health and Medical Research Council in Australia and the New Zealand Ministry of Health. The value of evaluating defective mismatch repair is acknowledged not only for Lynch syndrome screening but also for therapeutic decision information in patient management. AGPS advocates appropriate government funding for the molecular tests necessary for Lynch syndrome screening (BRAF mutation, MLH1 methylation testing).

Identifiants

pubmed: 30851981
pii: S0031-3025(18)30368-4
doi: 10.1016/j.pathol.2018.11.014
pii:
doi:

Types de publication

Editorial Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

233-239

Informations de copyright

Copyright © 2019 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Auteurs

Masato Yozu (M)

Histopathology Department, Middlemore Hospital, Auckland, New Zealand.

M Priyanthi Kumarasinghe (MP)

PathWest, QEII Medical Centre and School of Pathology and Laboratory Medicine, University of Western Australia, Perth, WA, Australia.

Ian S Brown (IS)

Envoi Specialist Pathologists, Brisbane, Qld, Australia; Department of Anatomical Pathology, Pathology Queensland, Brisbane, Qld, Australia.

Anthony J Gill (AJ)

Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, NSW, Australia; NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, NSW, Australia; University of Sydney, Sydney, NSW, Australia.

Christophe Rosty (C)

Envoi Specialist Pathologists, Brisbane, Qld, Australia; Faculty of Medicine, University of Queensland, Brisbane, Qld, Australia; Department of Pathology, University of Melbourne, Melbourne, Vic, Australia. Electronic address: c.rosty@uq.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH